TRAIL-Induced Apoptosis in TRAIL-Resistant Breast Carcinoma Through Quercetin Cotreatment
Breast cancer is the most commonly diagnosed cancer in women. There is a continued interest for the development of more efficacious treatment regimens for breast carcinoma. Recombinant human tumor necrosis factor–related apoptosis-inducing ligand (rhTRAIL) shows potential as a potent anticancer ther...
Main Authors: | Jasmine M Manouchehri, Katherine A Turner, Michael Kalafatis |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-01-01
|
Series: | Breast Cancer: Basic and Clinical Research |
Online Access: | https://doi.org/10.1177/1178223417749855 |
Similar Items
-
RhTRAIL with Sensitizing Agents for Breast Carcinoma Treatment
by: Manouchehri, Jasmine Marie
Published: (2018) -
Pterostilbene enhances TRAIL-induced apoptosis in TRAIL-resistant triple negative breast cancer cells
by: Yi-Jung Hsieh, et al.
Published: (2013) -
TRAIL Receptor Expression and TRAIL-mediated Apoptosis in Hepatocellular Carcinoma
by: Chia-hsien Yeh, et al.
Published: (1999) -
TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors
by: Xi Yang, et al.
Published: (2017-01-01) -
Pterostilbene enhances TRAIL-induced apoptosis in TRAIL-resistant triple negative breast cancer cells via the ER stress and CHOP upregulation
by: Li-Chieh Chien, et al.
Published: (2015)